INTRODUCTION
In the development of multicellular organisms, various signaling pathways are activated in a highly coordinated manner to ensure proper morphogenesis. Secreted signaling molecules such as fibroblast growth factors (Fgfs), bone morphogenic proteins (Bmps), Wnts, and Hedgehogs play crucial roles in development by influencing the intracellular signaling events of their neighbors from a distance. 1, 2) Fgfs are polypeptide growth factors with diverse biological activities. Most Fgfs mediate their biological responses by binding to and activating cell surface tyrosine kinase Fgf receptors (Fgfrs). The Fgf signalling system is required in multiple developmental processes including differentiation, cell proliferation, and migration. [3] [4] [5] In this paper, I provide a succinct review of the Fgf gene families in humans, mice, and zebrafish and their evolutionary processes and roles in development, metabolism, and disease.
THE HUMAN/MOUSE FGF GENE FAMILY
Two Fgfs, acidic Fgf (Fgf1) and basic Fgf (Fgf2), were originally isolated from the brain and pituitary gland as growth factors for fibroblasts. The genes for Fgf1 and Fgf2 are widely expressed in developing and adult tissues. 6, 7) Thereafter, seven Fgfs were also identified or isolated. The genes for Fgf3-Fgf6 were identified as oncogenes. [8] [9] [10] [11] On the other hand, Fgf7, Fgf8, and Fgf9 proteins were isolated as growth factors for keratinocytes, an androgen-induced growth factor from carcinoma cells, and a glia-activating factor from glioma cells, respectively. [12] [13] [14] These Fgf genes are expressed predominantly during embryonic development and are also expressed in restricted adult tissues, indicating their potential roles in development.
Fgf1-Fgf9 have a conserved ca. 120-amino acid residue core with ca. 30-70% sequence identity, although they are proteins of different sizes ranging from ca. 150 to 250 amino acid residues. 3, 4) We tried to identify new Fgf genes by conducting homology-based polymerase chain reaction (PCR) and homology-based searches in nucleotide sequence databases based on their conserved amino acid sequences. We successfully isolated or identified Fgf10, Fgf16, Fgf17, Fgf18, Fgf20, and Fgf21 by PCR [15] [16] [17] [18] [19] [20] and Fgf19, Fgf22, and Fgf23 by searching nucleotide sequence databases. [21] [22] [23] In addition, Smallwood et al. 24) isolated or identified Fgf11-Fgf14 genes from the retina by using a combination of random cDNA sequencing, homology-based searches of nucleotide sequence databases, and homology-based PCR.
McWhirter et al. 25) also isolated the Fgf15 gene as a downstream target of the chimeric homoeodomain oncoprotein E2A-Pbx1. Fgf1-Fgf23 have been identified in humans and mice. However, the human FGF15 and mouse Fgf19 genes have not been identified. The location of the human FGF19 and mouse Fgf15 genes on chromosomes indicates that FGF19 is a human ortholog of mouse Fgf15. Thus the human and mouse Fgf gene families comprise twenty-two members. 3, 4) Most Fgfs are secreted proteins with cleavable N-terminal signal peptides.
3) Fgf9, Fgf16, and Fgf20 with uncleaved bipartite signal sequences are also secreted proteins. 26, 27) By contrast, Fgf1, Fgf2, and Fgf11-Fgf14 without N-terminal hydrophobic sequences are not typical secreted proteins. Fgf1 and Fgf2 might be released from damaged cells or by an exocytotic mechanism that is independent of the endoplasmic reticulum-Golgi pathway. 28) Fgf11-Fgf14 are not secreted, but function within cells. 29) (Fig. 1) . 4) Phylogenetic analysis indicates potential evolutionary relationships in the gene family. However, it alone is not sufficient to determine these relationships. 32 (Fig. 3) .
During evolution, the Fgf gene family appears to have expanded in two phases. In the first phase, during early metazoan evolution, Fgf genes increased from two or three to six genes by gene duplication. In the second phase, during the evolution of early vertebrates, the Fgf gene family expanded via two large-scale gen(om)e duplications. Three or four members of the vertebrate subfamilies were potentially generated in the second phase (Fig. 3) . 4) Four members of the vertebrate Fgfr gene family were also potentially generated Twenty-two FGFs have been identified. Phylogenetic analysis suggests that the FGFs can be arranged into seven subfamilies containing two to four members each. Branch lengths are proportional to the evolutionary distance between each gene. FGF19 is a human ortholog of mouse Fgf15. Gene maps were constructed by examining human FGF gene loci using the Ensembl Genome Browser (http://www.ensembl.org/). FGF gene loci and closely linked genes are shown. Gene symbols are described according to the browser. The conservation of gene order supports a model for large-scale genome duplication events. during this phase. 4) This co-evolution has permitted the evolution of increased ligand-receptor specificity, enabling the formation of preferred ligand-receptor interactions. In addition, the alternative splicing of Fgfrs has increased their functional diversity. The mechanisms that regulate alternative splicing have been conserved since the divergence of echinoderms and vertebrates.
34) The expansion of the Fgf and Fgfr gene families has enabled this signaling system to acquire diversity of function and a nearly ubiquitous involvement in many developmental and physiological processes.
ACTIVATION OF FGFR PROTEINS BY FGF PRO-TEINS
Most Fgf signaling is mediated by activation of Fgfr proteins. Fgf proteins bind to Fgfr proteins and induce their dimerization and the phosphorylation of specific cytoplasmic tyrosine residues. The phosphorylation of Fgfrs triggers activation of cytoplasmic signal transduction pathways. This activation results in the activation of several signal transduction pathways eliciting different cell responses. Major Fgf-dependent signaling is mediated by the RAS/MAP kinase and the phospholipase-C gamma pathways. 5) Most Fgfs efficiently activate Fgfrs with different degrees of specificity. Members of the same FGF subfamily have essentially similar specificity. 30, 31) Fgfr activation by Fgf is also modulated by glycosaminoglycan chains including heparan sulfate. In the presence of heparan sulfate, Fgfs stably bind to Fgfrs, which leads to the formation of 2 : 2 : 2 Fgf-Fgfr-heparan sulfate dimers. 35) By contrast, the Fgf19 subfamily members, Fgf19, Fgf21, and Fgf23, much less efficiently activate Fgfrs. 31) Fgf21 and Fgf23 require coreceptors, b Klotho and Klotho, respectively, to activate Fgfrs efficiently. 36, 37) Fgf11-Fgf14 bear strong sequence similarity to other Fgfs. However, the biochemical and functional properties of Fgf11-Fgf14 are largely unrelated to those of other Fgfs. Fgf11-Fgf14 function within cells in an Fgfr-independent manner. 29) 
ROLES OF FGFS INDICATED BY FGF KNOCKOUT MICE
The mouse is a widely used vertebrate model for studying functions of genes. To elucidate physiological roles of Fgf10 and Fgf18 in vivo, we generated Fgf10 and Fgf18 knockout mice. Although these knockout mice died shortly after birth, their phenotypes indicate that these Fgfs play crucial roles in development. Fgf10 is critical to the development of multiple organs and tissues including the limb, lung, and white adipose tissue. [38] [39] [40] [41] Fgf18 also has crucial roles in skeletal and lung development. [42] [43] [44] Most Fgf genes have been disrupted by homologous recombination in mice. Phenotypes range from early embryonic lethality to subtle changes in adult mice (Table 1) ment of the lung and testes. 45, 46) In contrast, since Fgf4 and Fgf8 knockout mice die at early embryonic stages, the roles of these genes in vivo remain mostly unclear. 47, 48) Fgf15 knockout mice showing abnormal cardiac outflow tract gradually die in embryonic and postnatal stages. 49) Fgf23 knockout mice showing growth retardation and abnormal phosphate vitamin D metabolism also gradually die in the postnatal stages. 50) However, other Fgf knockout mice are viable with subtle phenotypes. The functions of these Fgfs might be redundant. Therefore the physiological roles of most Fgf genes in mice still remain unclear.
THE ZEBRAFISH FGF GENE FAMILY
The zebrafish is also a widely used vertebrate model for studying functions of genes. Because zebrafish embryos are small, the fertilization and subsequent embryonic development occur externally, and the development is rapid, 51) phenotypes of zebrafish embryos in which the functions of genes are blocked-the knockout of which is lethal at early embryonic stages in mice-can be potentially analyzed. In a largescale screening, many zebrafish mutants, which were mutagenized with ethylnitrosourea, displaying distinct phenotypes in embryos were generated. 52) Furthermore, antisense morpholino oligonucleotides can easily block the functions of multiple genes in zebrafish embryos. 53) Therefore the zebrafish is expected to be a useful vertebrate model for studying physiological functions of fgf genes in vivo.
Sixteen zebrafish fgf genes have been published or deposited in DNA databases. We also have identified eleven members of the zebrafish fgf family by conducting a homology-based search in the zebrafish genome and cDNA databases. The genes were named fgf1, fgf5, fgf6b, fgf7, fgf10b, fgf11, fgf12, fgf13, fgf14, fgf22, and fgf23 essentially based on the similarity in the amino acid sequences encoded by them to those of human FGFs. 54) Almost all potential zebrafish orthologs of human FGFs except for FGF9 have been identified. The zebrafish fgf family comprises twenty-seven members. Gene location analysis of zebrafish fgfs indicated twenty-one orthologs of human FGFs and six paralogs in zebrafish (Table 2) . 54) Comparisons of mammalian genes with genes of teleost fish have shown that in teleosts, including zebrafish, there are often two homologs of the mammalian equivalent. This suggests that there has been an additional genome duplication shortly after the teleost radiation. This duplication must have been either a partial or a whole genome duplication followed by rapid gene loss because gene duplications account for only ca. 20% of the zebrafish genes examined.
51) The location analysis of zebrafish fgf genes indicates that zebrafish fgf paralogs were also generated by genome duplication and/or local gene duplication and translocation.
ROLES OF FGFS INDICATED BY ZEBRAFISH EM-BRYOS WITH MUTATED OR KNOCKDOWN FGFS
Several zebrafish fgf mutants have been generated by mutagenesis with ethylnitrosourea. acerebellar is a mutation of fgf8. acerebellar embryos lack a cerebellum and the midbrain-hindbrain boundary organizer. 55) ikarus is a mutation of fgf24. ikarus embryos lack pectoral fin buds. 56) daedalus is a mutation of fgf10. Daedalus embryos have no pectoral fin buds either and a severely dysmorphic hepatopancreatic ductal system. 57, 58) devoid of blastema is a mutation of fgf20a. devoid of blastema embryos have no pectoral fin buds. 59) These results indicate that zebrafish fgfs also play crucial roles in development.
We generated fgf16, fgf19, and fgf21 knockdown zebrafish embryos using antisense morpholino oligonucleotides. Phenotypes of these embryos indicate that fgf16, fgf19, and fgf21 are required for the fin buds to form, 60) the forebrain to develop, 61) and haematopoiesis, 62) respectively. In addition, the roles of some other fgfs also have been demonstrated by using fgf knockdown embryos. fgf3 and fgf8 are required together for formation of the otic placode and vesicle. 63) fgf1 is required for normal differentiation of erythrocytes. 64) These results also indicate that these fgfs play crucial roles in development. Now, it seems likely that all members of the zebrafish fgf family have been identified. fgf knockdown experiments with antisense morpholino oligonucleotides will promote our understanding of fgf functions in zebrafish.
FGFS AS HUMORAL REGULATORS IN METABO-LISM
Most Fgfs play roles in development as proliferation and/or differentiation factors in a paracrine and/or autocrine manner. However, the Fgf19 subfamily members potentially function as metabolic regulators in an endocrine manner. Fgf19 potentially acts to regulate energy, lipid, and bile acid metabolism. 65, 66) Fgf21 potentially regulates energy, lipid, and glucose metabolism. 67, 68) Fgf23 also potentially regulates 
The human FGF and zebrafish fgf gene families comprise twenty-two and twentyseven members, respectively. FGF19 and fgf19 are human and zebrafish orthologs of mouse Fgf15. Zebrafish Fgf9 has not been identified. It might have been lost from the genome during evolution. Six paralogs of fgf genes have been identified in zebrafish. They were potentially generated by an additional genome duplication shortly after the teleost radiation.
phosphate and vitamin D metabolism. 69, 70) In addition, as described above, Fgf19, Fgf21, and Fgf23 much less efficiently activate Fgfrs. 31) Fgf21 and Fgf23 require coreceptors, b Klotho and Klotho, respectively, to activate Fgfrs efficiently. 36, 37) These results indicate that the Fgf19 subfamily members are unique Fgfs with potential unique roles and mechanisms of action.
FGF SIGNALING DISORDERS IN HUMAN DIS-EASE
As described, Fgf signaling is crucial to development. However, FGF signaling disorders also result in human hereditary diseases (Table 3) . Autosomal dominant hypophosphataemic rickets (ADHR) is characterized by low serum phosphorus concentrations, rickets, osteomalacia, low extremity deformities, short stature, bone pain, and dental abscesses. The ADHR gene is the FGF23 gene with mutations that stabilize the FGF23 protein. 71, 72) Tumor-induced osteomalacia (TIO) is one of the paraneoplastic diseases characterized by hypophosphataemia. Removal of responsible tumors normalizes phosphate metabolism. A humoral phosphaturic factor responsible for TIO is FGF23. 73) These results indicate that these diseases are caused by a gain-offunction of FGF23. Aplasia of lacrimal and salivary glands (ALSG) is an autosomal dominant congenital anomaly characterized by aplasia, atresia, or hypoplasia of the lacrimal and salivary systems. Lacrimo-auriculo-dento-digital syndrome (LADD) is an autosomal-dominant multiple congenital anomaly disorder characterized by aplasia, atresia, or hypoplasia of the lacrimal and salivary systems, cup-shaped ears, hearing loss, and dental and digital anomalies. Both ALSG and LADD are caused by FGF10 mutations. [74] [75] [76] [77] We originally identified Fgf20 as a neurotrophic factor preferentially expressed in dopaminergic neurons within the substantia nigra pars compacta of rat brain. 20) Parkinson disease (PD) is caused by a pathogenic process responsible for the loss of dopaminergic neurons within the substantia nigra pars compacta. A pedigree disequilibrium test and a case-control association study indicated that FGF20 is potentially a risk factor for PD. 78, 79) Börjeson-Forssman-Lehmann syndrome (BFLS) is a syndromal X-linked mental retardation. FGF13 is a candidate gene for BFLS. 80) Hereditary spinocerebellar ataxias (SCAs) are a clinically and genetically heterogeneous group of neurodegenerative disorders. One SCA with earlyonset tremor, dyskinesia, and slowly progressive cerebellar ataxia is caused by FGF14 mutations. 81) Michel aplasia is a unique autosomal recessive syndrome characterized by type I microtia, microdontia, and profound congenital deafness associated with a complete absence of inner ear structures. Michel aplasia is caused by FGF3 mutations. 82) As described above, FGF3-FGF6 were originally isolated as oncogenes. FGFs and FGFRs play crucial roles in cell proliferation. Therefore FGFs and FGFRs have been expected to be oncogenes with the potential to initiate and/or promote tumorigenesis. Compelling evidence has emerged to implicate FGFs and FGFRs in the genesis of cancers including mammary carcinogenesis, prostate carcinogenesis, skin tumorigenesis, urothelial cancer, and hematologic malignancies (reviewed in ref. 83) .
The importance of FGF signaling in human skeletal development was first revealed with the discovery of a point mutation in the transmembrane domain of FGFR3 in the etiology of achondroplasia, the most common genetic form of dwarfism in humans. The etiology of many other human skeletal dysplasias has been attributed to specific mutations in the genes encoding FGFR1, FGFR2, and FGFR3 (Table 3) (reviewed in ref. 84 ). These disorders can be broadly classified into two groups: (1) the dwarfing chondrodysplasia syndromes, which include hypochondroplasia (HCH), achondroplasia (ACH), and thanatophoric dysplasia (TD); and (2) the craniosynostosis syndromes, which include Apert syndrome (AS), Beare-Stevenson cutis gyrata, Crouzon syndrome (CS), Pfeiffer syndrome (PS), and a non-syndromic craniosynostosis (NSC). All of these mutations are autosomal dominant.
CONCLUDING REMARKS
Both the human and mouse Fgf and Fgfr gene families comprise twenty-two and four members, respectively. In contrast, the zebrafish fgf gene family comprises twenty-seven members with several parologs. Most Fgf proteins bind to Fgfr proteins and induce their dimerization and the phosphorylation of specific cytoplasmic tyrosine residues. The Fgf and Fgfr gene families greatly co-expanded during the evolution of early vertebrates. The expansion of the Fgf and Fgfr gene families has enabled this signaling system to acquire diversity of function and a nearly ubiquitous involvement in many developmental and physiological processes. Fgf knockout mice and zebrafish embryos with mutated or knockdown fgfs indicate that Fgfs play crucial roles in various developmental processes in a paracrine and/or autocrine manner. In addition, some Fgfs also play potential roles in metabolism in an endocrine manner. FGF signaling disorders also result in human hereditary diseases and cancers. 
